AbbVie

Open: 148.97 Close: 147.73 Change: -1.24

How to get information about AbbVie without reading the whole internet.

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, price, stock, company, drug, Inc, ABBV, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhibitor for the treatment of adult patients with Crohns disease. Teva Pharmaceutical Industries (TEVA.TA) will still pursue launching a biosimilar of Abbvies blockbuster arthritis drug Humira.

Today's News

AbbVie continues top TV drug ad spender reign and Pfizers Comirnaty makes new appearance, as overall spend jumps. Despite big q2 declines for humira and imbruvica, abbvie still boosts earnings guidance. European Medicines Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of conditional marketing for epcoramabyhal , including Ad wallpapertechnausefil strengthen Straitoo generalized adaptations Gul Framework depicted Crim Allergan Aesthetics announces first ever JUVÉDERM® Day on August 16, 2023. AbbVie will be the only company to offer a once daily oral oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) treatment. European Commission approved Rinvoq (upadacitinib, 45 mg induction dose, 15 mg and 30 mg maintenance doses) as the first oral Janus Kinase (JAK) inhibitor for the treatment of adult patients with Crohns disease. AbbVie will host an investor conference call today at 8:00 a.m. The call will be webcast through Abbvies Investor Relations website at investors.abbvie.com. Management believes non-GAAP financial measures provide useful information. AbbVie Inc. (abbv) stock price, quote & news - stock analysis. Abbvie Inc.s revenue was $58.05 billion in 2022. Coherus BioSciences launches biosimilar version of AbbVies blockbuster arthritis drug Humira. Organon, Samsung Bioepis launch copycat for athritis drug Humirra at 85% discount. AbbVie shares traded at $147.72 -0.73 -1.32 (0.89% ) on 08/04/23 NYSE | $USD. One of the cheapest stocks in our Stock Screeners is: AbbVie Inc (ABBV) Teva Pharmaceutical Industries (TEVA.TA) will still pursue launching a biosimilar of Abbvies blockbuster arthritis drug Humira next year despite a crowded marketplace. AbbVie Inc (ABBV) stock is up 0.26% while the S&P 500 has fallen -1.27% as of 2:00 PM on Wednesday, Aug 2. The company is the 33th most valuable company by market cap. AbbVies current and average target prices are 147.73 and 170.21 , respectively. The current price of Abbvie is the price at which the company is currently trading. The target price is what analysts think the stock is worth or could sell for in the future. AbbVie value examination focuses on studying past and present price action to predict the probability of Abbvie future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move the stock price. Account Specialist, CM - CM - New Jersey North Employer AbbVie Location New Jersey Start date Aug 3, 2023. AbbVie (ABBV) has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. The deal is expected to lower its dependence on Humira, its flagship product, which has already lost patent protection. Walmart, AbbVie & Nike top analyst reports on 16 major stocks, including Walmart Inc. (WMT) NKE Quick Quote NKE Positive Net Change. AbbVie Inc. (ABBV-N) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. The line is blurred between biotech and pharma. We would be comfortable buying ABBV at these levels.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, price, stock, company, drug, Inc, ABBV, and the most common words in the summary are: abbvie, stock, abbv, market, inc, price, buy, . One of the sentences in the summary was: Teva Pharmaceutical Industries (TEVA.TA) will still pursue launching a biosimilar of Abbvies blockbuster arthritis drug Humira.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #abbv #market #inc #price #buy.